tiprankstipranks
Can-Fite BioPharma (CANF)
:CANF
US Market

Can-Fite BioPharma (CANF) Financial Statements

Compare
557 Followers

Can-Fite BioPharma Financial Overview

Can-Fite BioPharma's market cap is currently $16.95M. The company's EPS TTM is $-1.857; its P/E ratio is ―; Can-Fite BioPharma is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 743.00K$ 810.00K$ 853.00K$ 763.00K$ 2.03M
Gross Profit$ 743.00K$ 810.00K$ 853.00K$ 763.00K$ 2.03M
Operating Income$ -8.20M$ -10.10M$ -12.84M$ -14.14M$ -12.01M
EBITDA$ -8.18M$ -10.08M$ -12.83M$ -14.13M$ -11.99M
Net Income$ -7.63M$ -10.17M$ -12.62M$ -14.44M$ -12.63M
Balance Sheet
Cash & Short-Term Investments$ 8.92M$ 7.98M$ 19.14M$ 8.34M$ 2.76M
Total Assets$ 9.99M$ 9.28M$ 20.25M$ 9.52M$ 8.17M
Total Debt$ 40.00K$ 62.00K$ 124.00K$ 67.00K$ 75.00K
Net Debt$ -4.24M$ -2.92M$ -4.27M$ -8.20M$ -2.62M
Total Liabilities$ 3.75M$ 4.81M$ 5.87M$ 3.45M$ 5.73M
Stockholders' Equity$ 6.24M$ 4.47M$ 14.38M$ 6.07M$ 2.44M
Cash Flow
Free Cash Flow$ -8.44M$ -10.81M$ -9.87M$ -12.09M$ -10.84M
Operating Cash Flow$ -8.44M$ -10.80M$ -9.86M$ -12.06M$ -10.83M
Investing Cash Flow$ 498.00K$ 9.50M$ -14.51M$ -26.00K$ -253.00K
Financing Cash Flow$ 9.14M$ 20.46M$ 20.46M$ 17.68M$ 10.17M
Currency in USD

Can-Fite BioPharma Earnings and Revenue History

Can-Fite BioPharma Debt to Assets

Can-Fite BioPharma Cash Flow

Can-Fite BioPharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis